Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by poor infiltration into the complex tumor ...

Metabolic reprogramming in the tumor microenvironment shapes immune function and therapy resistance, offering insights into ...

Gastric (stomach) cancer remains one of the most common and deadly cancers in East Asia, including Korea. Yet despite its high prevalence, it has received far less molecular attention than colorectal ...

By recreating a fetal liver niche, FLOs show how liver and immune cells co-develop. Learn more about new groundbreaking ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...

Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by ...

Various tissues and organs in the human body, such as nerves, heart, bones, and skin, rely on bioelectrical signals to maintain function and support ...

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...

HURA READ THE FULL HURA RESEARCH REPORT ASH Presentation TuHURA (NASDAQ:HURA)  addressed the American Society of Hematology (ASH) Annual Meeting and Exposition with a presentation and poster on Sunday ...

Researchers have identified the mechanism by which cancer cells create their own growth signals to proliferate, independent ...